Drug intelligence / Profile preview

probiotic blend-University of Tehran

Development stage: Unknown
Lead developer: University of Tehran
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

probiotic blend-University of Tehran is a specific synbiotic formulation containing a combination of 12 probiotic strains and the prebiotic fructooligosaccharides (FOS). The blend includes various species of Lactobacillus (L. rhamnosus, L. plantarum, L. casei, L. helveticus, L. acidophilus, L. bulgaricus, and L. gasseri), Bifidobacterium (B. bifidum, B. lactis, B. breve, and B. longum), and Streptococcus thermophilus. Developed for research by the University of Tehran, it is primarily investigated for its effects on the gut-brain-microbiome axis. The formulation is being studied for its potential to improve cognitive control, reduce impulsivity, and influence food selection in overweight individuals, potentially serving as a therapeutic intervention for obesity management.

Other names: Probiotic Blend Capsule

Beyond the preview

Go deeper on probiotic blend-University of Tehran.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on probiotic blend-University of Tehran.

Explore the full profile